| Grant number: | 11/00128-1 |
| Support Opportunities: | Regular Research Grants |
| Start date: | July 01, 2011 |
| End date: | June 30, 2013 |
| Field of knowledge: | Biological Sciences - Morphology - Histology |
| Principal Investigator: | Sonia Maria Oliani |
| Grantee: | Sonia Maria Oliani |
| Host Institution: | Instituto de Biociências, Letras e Ciências Exatas (IBILCE). Universidade Estadual Paulista (UNESP). Campus de São José do Rio Preto. São José do Rio Preto , SP, Brazil |
| City of the host institution: | São José do Rio Preto |
| Associated researchers: | Cristiane Damas Gil |
Abstract
Inflammation is the main contributing factor for many ocular disorders. Pharmacological treatment of such conditions includes corticosteroids and chemotherapeutic agents, whose side effects (glaucoma and cytotoxicity) limit their use and stimulate search for new therapeutic strategies. Annexin-A1 (ANXA1), a 37 kDa protein, possesses anti-inflammatory activities, however, is rarely explored in normal and inflamed ocular tissues. Thus, we will investigate, in vivo and in vitro, the expression and the mechanism of action of endogenous ANXA1 protein in rat ocular tissues and in ARPE-19 cells derived from the human retinal pigmented epithelium (RPE) in normal and after the inflammation process induced by endotoxin. We will also investigate the possible anti-inflammatory effect of the administration of the peptide AC2-26 of the ANXA1 in those experimental conditions. Studies will be conducted by histopathological and quantitative analysis of neutrophils in ocular tissues and aqueous humor, immunohistochemical protein expression of ANXA1, ANXA1 phosphorylated in serine (ANXA1-S27-PO4) and tyrosine (ANXA1-T21-PO4) and FPR²2 in ocular tissues, immunocytochemical expressions of ANXA1 and COX-2 in ARPE-19 cells, biochemical parameters (TNF-±, IL-1², IL6, IL8, MCP1 and NO levels in supernatants of ocular tissues and/or ARPE-19 cells) and molecular studies (eletromobilility gel assay to quantify the activity of NFºB in ARPE-19 cells). The integrated results obtained from the in vivo and in vitro analyses might indicate the mechanism of action of ANXA1 in ocular inflammatory processes and provide new therapies to treat these conditions. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |